Orthocell LtdASX: OCC

Major Milestone with First Sales of Remplir in Singapore

· Issued by Orthocell Ltd

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Orthocell Ltd has announced its first sales of the Remplir peripheral nerve repair device in Singapore, marking a significant milestone in its commercialization efforts. The initial sales occurred ahead of a planned market launch, indicating strong demand and the effectiveness of its distribution partner, Device Technologies Asia. The company is also preparing for expansion into the U.S. market with expected regulatory approvals in the near future. Orthocell maintains a strong financial position with substantial cash reserves to support its growth initiatives.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Orthocell Ltd on 6ix

Story so far

Earlier from Orthocell

Later from Orthocell

All Orthocell news releases